Möchten Sie immer auf dem neuesten Stand bleiben?

- For the nine months ended September 30, 2023, revenues of $11.7 million represent an increase of 339% compared to $2.6 million for the same period in 2022 COSTA MESA, CA., Nov. 28, 2023 ...

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...

SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer...

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a novel class of antigensBroad Applicability –...

Results from pre- clinical trial indicate potential effect in various metabolic parameters including fat oxidation, weight loss and reduced appetite Tel Aviv, Israel / Vancouver, Canada, Nov. ...

The pre- clinical trial conducted using the combined treatment of SciSparc's proprietary CannAmide™ and Clearmind Medicine's MEAI molecule TEL AVIV, Israel, Nov. 28, 2023 (GLOBE NEWSWIRE) -- ...

Cohort 9 Following completion of the 21-day observation period at 3.4 mg/kg (Cohort 9), no dose limiting toxicities (DLTs) or serious adverse events (SAEs) were observed Two patients in Cohort 9...

Stryve Foods Announces Major Distribution Expansion into Leading Retailers Across the United States

Celebration, FL, Nov. 28, 2023 (GLOBE NEWSWIRE) -- La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a holding company for five agent-centric, technology-integrated, cloud-based,...

Connexa Records 59 Percent Improvement in Operating Loss for Quarter Ended October 2023 and 72 Percent Improvement Year-to-Date.Operating Expenses Reduced 60 Percent Year-on-Year.Positive NET INCOME...